Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Sigma Receptors: Their Role in Disease and as Therapeutic Targets -

Sigma Receptors: Their Role in Disease and as Therapeutic Targets

Buch | Softcover
XIII, 312 Seiten
2018 | 1. Softcover reprint of the original 1st ed. 2017
Springer International Publishing (Verlag)
978-3-319-84335-3 (ISBN)
CHF 249,95 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken

Originally confused with opioid receptors and then orphan receptors with no biological function, Sigma Receptors are now recognized as relevant to many degenerative diseases with remarkable potential as therapeutic targets. In this text, new information about the structure of sigma 1 receptor, its binding sites are provided as well as its expression in many cell types.  It's putative role in degenerative neuronal diseases including amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, pain, drug addiction and locomotor activity. Their roles in possible treatments for blinding retinal diseases emphasize the tremendous far-reaching potential for ligands for these receptors.  Exciting breakthroughs in this dynamic field in the last decade are reported herein, which will guide future investigators in determining the full potential of this unique, yet abundantly expressed protein.

Foreword.- Chap. 1 Anti-depressant functions of sigma receptor 1.- Chap. 2 Parkinsonism.- Chap. 3 New ligands for sigma receptors and studies of ligand binding sites.- Chap. 4 sR1 and neurite elongation.- Chap. 5 Studies of sR1 in ALS,  photaffinity probes and oxidative stress.- Chap. 6 sR1: Pharmacology and protective effects.- Chap. 7 Anti-stroke and anti-excitotoxicity.- Chap. 8 sR1 as a molecular chaperone.- Chap. 9 The potential role of sR1 as a neuroprotective.- Chap. 10 Studies of sR1 and effects on VGCC (calcium channels).- Chap. 11 The role of sR1 in retinal neuroprotection.- Index.

Erscheint lt. Verlag 13.6.2018
Reihe/Serie Advances in Experimental Medicine and Biology
Zusatzinfo XIII, 312 p. 59 illus., 45 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 178 x 254 mm
Gewicht 849 g
Themenwelt Medizin / Pharmazie Studium
Naturwissenschaften Biologie Biochemie
Schlagworte Drug Target • Molecular Chaperone • Neurodegeneration • Neuroprotection • receptors • Sigma 1 Receptor
ISBN-10 3-319-84335-4 / 3319843354
ISBN-13 978-3-319-84335-3 / 9783319843353
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Reinhard Matissek; Andreas Hahn

Buch | Hardcover (2024)
Springer Spektrum (Verlag)
CHF 109,95

von Birgit Piechulla; Hans Walter Heldt

Buch | Hardcover (2023)
Springer Spektrum (Verlag)
CHF 109,95